Abstract:Mutations of the adenomatous polyposis coli tumor suppressor gene, or its downstream target β‐catenin, have been implicated in the initiation of most sporadic human colorectal epithelial neoplasms. These mutations, in turn, lead to aberrant nuclear accumulation of β‐catenin and subsequent activation of the β‐catenin/Tcf transcription factor complex. In vitro studies utilizing cultured human colon cancer cell lines have identified c‐myc, cyclin D1 and fra‐1 as target genes of β‐catenin/Tcf signaling. In our study, 12 cases of human colorectal adenocarcinomas were examined by Western immunoblotting analysis and immunohistochemical staining to specifically investigate whether the protein expression of these target genes was indeed altered in vivo by β‐catenin dysregulation. The results show that the protein level of β‐catenin was significantly increased in all 12 tumors (3.4 ± 1.0‐fold increase compared to the control normal mucosa by Western immunoblotting, p < 0.05), and this increase was associated with positive nuclear staining by immunohistochemistry in 10 cases. Increased levels of expression of cyclin D1 and Fra‐1 proteins were also demonstrated in every tumor (9.0 ± 2.7 and 3.3 ± 0.9‐fold increases compared to normal mucosa, respectively). Surprisingly, the protein level of c‐Myc was significantly decreased in all tumors examined by 49 ± 19% (p < 0.05), but the c‐myc mRNA level was increased in 8 of 12 tumors when compared to that in normal mucosa by RT‐PCR. Immunohistochemical staining performed on these carcinomas and additional 27 colorectal carcinomas further demonstrated that the protein expression level of c‐Myc and β‐catenin nuclear localization were not correlated. Moreover, 15 of 20 colorectal adenomas exhibited positive nuclear β‐catenin immunostaining, among which 11 also exhibited increased c‐Myc protein expression. These data thus support the notion that upregulation of cyclin D1 and Fra‐1 in human colorectal adenocarcinomas is driven by abnormally expressed β‐catenin. However, the regulation of c‐myc expression in colorectal tumors appears to be more complex. While dysregulated β‐catenin may cause a transcriptional upregulation of the c‐myc gene, the c‐Myc protein expression appears to be further regulated by a posttranscriptional mechanism(s) during the process of neoplastic progression. © 2002 Wiley‐Liss, Inc.

Tyrosine-phosphorylation of the 12th armadillo-repeat of beta-catenin is associated with cadherin dysfunction in human cancer

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

δ-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles

Switching of the Substrate Specificity of Protein Tyrosine Phosphatase N12 by Cyclin‐dependent Kinase 2 Phosphorylation Orchestrating 2 Oncogenic Pathways

Protein-tyrosine Phosphatase PCP-2 Inhibits Β-Catenin Signaling and Increases E-cadherin-dependent Cell Adhesion*

Physical and Functional Interaction Between Receptor-Like Protein Tyrosine Phosphatase PCP-2 and Beta-Catenin.

Tyrosine Residues 654 and 670 in Β-Catenin Are Crucial in Regulation of Met–β-catenin Interactions

Beta- and Gamma-Catenin Mutations, but Not E-cadherin Inactivation, Underlie T-cell Factor/lymphoid Enhancer Factor Transcriptional Deregulation in Gastric and Pancreatic Cancer.

Modulation Of Beta-Catenin Signaling By The Inhibitors Of Map Kinase, Tyrosine Kinase, And Pi3-Kinase Pathways

Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity

beta-Catenin regulates the expression of tenascin-C in human colorectal tumors

Phosphorylation of human CEACAM1-LF by PKA and GSK3β promotes its interaction with β-catenin

Phosphorylation Of Beta-Catenin By Akt Promotes Beta-Catenin Transcriptional Activity

Regulation of the phosphorylation and nuclear import and export of β-catenin by APC and its cancer-related truncated form.

Cathelicidin, An Antimicrobial Peptide Produced By Macrophages, Promotes Colon Cancer By Activating The Wnt/Beta-Catenin Pathway

Α-Catenin Acetylation is Essential for Its Stability and Blocks Its Tumor Suppressor Effects in Breast Cancer Through Yap1

Egf-Induced Erk Activation Promotes Ck2-Mediated Disassociation of Alpha-Catenin from Beta-Catenin and Transactivation of Beta-Catenin

Nuclear E-cadherin acetylation promotes colorectal tumorigenesis via enhancing β-catenin activity.

Regulation of Met‐β‐catenin Interaction in Hepatocytes by Tyrosine Phosphorylation

Elevated Protein Expression of Cyclin D1 and Fra‐1 but Decreased Expression of C‐myc in Human Colorectal Adenocarcinomas Overexpressing Β‐catenin

Regulation of a Calcium-dependent Tyrosine Kinase in Vascular Smooth Muscle Cells by Angiotensin II and Platelet-derived Growth Factor